Go to AAD Home
Donate For Public and Patients Store Search
Go to AAD Home
Main menu
Membership
Meetings & Education
Practice management
Clinical & quality
Publications & apps
Career development
Advocacy
Back
Account
Pay dues
Member ID
Join the AAD
Member benefits
Find a member
AAD governance
Support AAD
Community Programs
AAD Help Center
2026 Annual Meeting
2026 Innovation Academy
Academy meetings archive
Professional education
Claim CME & view transcript
Upcoming events
Residents & medical students
Patient education materials
DataDerm
Coding Resource Center
MIPS & fee schedule
Teledermatology
EHR & health tech
Insurance & drugs
Compliance & practice scope
Managing your practice
Contact PM staff
Clinical guidelines
Quality measures
DataDerm
Quality & patient safety
Clinical Community
Clinical care resources
Position statements
JAAD
JAAD International
JAAD Case Reports
Dermatology World
DermWorld Insights & Inquiries
Derm Coding Consult
DermWorld Meeting News
Impact Report
Other publications
Academy Apps
Career launch
Job board
Burnout & wellness
Diversity
Awards, grants, and scholarships
Leadership Institute
Volunteer opportunities
Ethics & professionalism
Take action
Advocacy priorities
State advocacy resources
Legislative Conference
Position statements
Promote the specialty
Key Contacts
Patient advocate resources
SkinPAC
Advocacy Update
Welcome!

American Academy of Dermatology Association Statement on FDA Proposal for New Sunscreen Ingredient

Statement from Susan C. Taylor, MD, FAAD, President, American Academy of Dermatology

ROSEMONT, Ill. (Dec. 11, 2025) — The American Academy of Dermatology Association applauds the Food and Drug Administration for taking the first steps in more than two decades to provide more safe and effective sunscreen options to the American public. The agency announced today that they are proposing to add a new sunscreen ingredient to protect the public’s health.

Unprotected exposure to UV rays is a major risk factor for skin cancer, the most common cancer in the United States. It is estimated that one in five Americans will develop skin cancer in their lifetime and nearly 20 Americans die from melanoma, the deadliest form of skin cancer, every day.

Because dermatologists see first-hand the impact that skin cancer has on patients and their families, they recommend everyone apply sunscreen, seek shade, and wear protective clothing to protect their skin from sunburn, early skin aging, and skin cancer. The Academy recommends that everyone use a broad-spectrum, water-resistant sunscreen with an SPF of 30 or higher on skin not protected by clothing when outside.

The Academy has been advocating for many years for the availability of more sunscreen options for U.S. consumers. The United States lags behind many other countries that have nearly twice as many approved sunscreen ingredients.

The Academy remains committed to supporting and enhancing patient care. If you have questions about skin cancer and sun protection, partner with a board-certified dermatologist.

# # #

Contact

Shelby Homiston, shomiston@aad.org

Media Relations, mediarelations@aad.org

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more than 21,000 physicians worldwide, the AAD is committed to advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair, and nails; advocating high standards in clinical practice, education and research in dermatology; and supporting and enhancing patient care because skin, hair, and nail conditions can have a serious impact on your health and well-being. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow @AADskin on  Facebook, TikTok, Pinterest, and YouTube, and @AADskin1 on Instagram.

Editor’s note: The AAD does not promote or endorse any products or services. This content is intended as editorial content and should not be embedded with any paid, sponsored or advertorial content as it could be perceived as an AAD endorsement.